These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25762364)

  • 1. Cytokine-Enhanced Vaccine and Interferon-β plus Suicide Gene Therapy as Surgery Adjuvant Treatments for Spontaneous Canine Melanoma.
    Finocchiaro LM; Fondello C; Gil-Cardeza ML; Rossi ÚA; Villaverde MS; Riveros MD; Glikin GC
    Hum Gene Ther; 2015 Jun; 26(6):367-76. PubMed ID: 25762364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine-enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma: 9 years of follow-up.
    Finocchiaro LM; Glikin GC
    Cancer Gene Ther; 2012 Dec; 19(12):852-61. PubMed ID: 23059870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of cytokine-enhanced vaccine and chemo-gene therapy as surgery adjuvant treatments for spontaneous canine melanoma.
    Finocchiaro LME; Agnetti L; Fondello C; Glikin GC
    Gene Ther; 2019 Nov; 26(10-11):418-431. PubMed ID: 30858538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma.
    Finocchiaro LM; Glikin GC
    Gene Ther; 2008 Feb; 15(4):267-76. PubMed ID: 18033308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suicide gene and cytokines combined nonviral gene therapy for spontaneous canine melanoma.
    Finocchiaro LM; Fiszman GL; Karara AL; Glikin GC
    Cancer Gene Ther; 2008 Mar; 15(3):165-72. PubMed ID: 18219342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-enhanced vaccine and interferon-β plus suicide gene as combined therapy for spontaneous canine sarcomas.
    Finocchiaro LM; Villaverde MS; Gil-Cardeza ML; Riveros MD; Glikin GC
    Res Vet Sci; 2011 Oct; 91(2):230-4. PubMed ID: 21300385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
    MacEwen EG; Kurzman ID; Vail DM; Dubielzig RR; Everlith K; Madewell BR; Rodriguez CO; Phillips B; Zwahlen CH; Obradovich J; Rosenthal RC; Fox LE; Rosenberg M; Henry C; Fidel J
    Clin Cancer Res; 1999 Dec; 5(12):4249-58. PubMed ID: 10632367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma.
    Treggiari E; Grant JP; North SM
    J Vet Med Sci; 2016 Jun; 78(5):845-50. PubMed ID: 26781703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suicide plus immune gene therapy prevents post-surgical local relapse and increases overall survival in an aggressive mouse melanoma setting.
    Villaverde MS; Combe K; Duchene AG; Wei MX; Glikin GC; Finocchiaro LM
    Int Immunopharmacol; 2014 Sep; 22(1):167-75. PubMed ID: 24973616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma.
    Dow SW; Elmslie RE; Willson AP; Roche L; Gorman C; Potter TA
    J Clin Invest; 1998 Jun; 101(11):2406-14. PubMed ID: 9616212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma.
    von Euler H; Sadeghi A; Carlsson B; Rivera P; Loskog A; Segall T; Korsgren O; Tötterman TH
    J Immunother; 2008 May; 31(4):377-84. PubMed ID: 18391758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.
    Piras LA; Riccardo F; Iussich S; Maniscalco L; Gattino F; Martano M; Morello E; Lorda Mayayo S; Rolih V; Garavaglia F; De Maria R; Lardone E; Collivignarelli F; Mignacca D; Giacobino D; Ferrone S; Cavallo F; Buracco P
    Vet Comp Oncol; 2017 Sep; 15(3):996-1013. PubMed ID: 27146852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality treatment including ONCEPT for canine oral melanoma: A retrospective analysis of 131 dogs.
    Turek M; LaDue T; Looper J; Nagata K; Shiomitsu K; Keyerleber M; Buchholz J; Gieger T; Hetzel S
    Vet Radiol Ultrasound; 2020 Jul; 61(4):471-480. PubMed ID: 32323424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined use of irradiation and DNA tumor vaccine to treat canine oral malignant melanoma: a pilot study].
    Herzog A; Buchholz J; Ruess-Melzer K; Lang J; Kaser-Hotz B
    Schweiz Arch Tierheilkd; 2013 Feb; 155(2):135-42. PubMed ID: 23385072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Suicide and Cytokine Gene Therapies as Surgery Adjuvant for Canine Mammary Carcinoma.
    Finocchiaro LME; Spector AIM; Agnetti L; Arbe MF; Glikin GC
    Vet Sci; 2018 Aug; 5(3):. PubMed ID: 30081470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision.
    Dank G; Rassnick KM; Sokolovsky Y; Garrett LD; Post GS; Kitchell BE; Sellon RK; Kleiter M; Northrup N; Segev G
    Vet Comp Oncol; 2014 Mar; 12(1):78-84. PubMed ID: 22737988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor.
    Spitler LE; Grossbard ML; Ernstoff MS; Silver G; Jacobs M; Hayes FA; Soong SJ
    J Clin Oncol; 2000 Apr; 18(8):1614-21. PubMed ID: 10764421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2.
    Quintin-Colonna F; Devauchelle P; Fradelizi D; Mourot B; Faure T; Kourilsky P; Roth C; Mehtali M
    Gene Ther; 1996 Dec; 3(12):1104-12. PubMed ID: 8986437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001-2012).
    Boston SE; Lu X; Culp WT; Montinaro V; Romanelli G; Dudley RM; Liptak JM; Mestrinho LA; Buracco P
    J Am Vet Med Assoc; 2014 Aug; 245(4):401-7. PubMed ID: 25075823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of bleomycin with suicide or interferon-β gene transfer is able to efficiently eliminate human melanoma tumor initiating cells.
    Fondello C; Agnetti L; Villaverde MS; Simian M; Glikin GC; Finocchiaro LME
    Biomed Pharmacother; 2016 Oct; 83():290-301. PubMed ID: 27399807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.